Nov 5 (Reuters) - Integral Diagnostics Ltd (IDX) :
- UP UNTIL 31 OCT, YEAR TO DATE REVENUE IS UP ABOUT 4.8% ON PRIOR YEAR REVENUE
- SLOWLY SEEING A RETURN OF EXAMINATION VOLUMES
- EXPECT TO INVEST A$20 MILLION-A$24 MILLION IN BROWNFIELDS AND GREENFIELDS IN FY22, ON 5 NEW SITES ACROSS VIC, NZ, WA AND QLD
- ON-GOING IMPACTS OF COVID-19 INCLUDING SUPPLY CHAIN PRESSURES CONTINUE TO IMPACT ABILITY TO RETURN TO EXPECTED PERFORMANCE
News: IDX Integral Diagnostics Says Up Until 31 Oct, Year To Date Revenue Is Up About 4.8%
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.90 |
Change
0.050(1.75%) |
Mkt cap ! $1.080B | |||
| Open | High | Low | Value | Volume |
| $2.90 | $2.90 | $2.84 | $1.884M | 653.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1748 | $2.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.99 | 25400 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
| IDX (ASX) Chart |